CIRM Board Approves New Clinical Trial for ALS

This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) awarded $11.99 million to Cedars-Sinai to fund a clinical trial for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.  ALS is a neurodegenerative disease that results in the death of nerve cells in the brain and spinal cord, causing … Continue reading CIRM Board Approves New Clinical Trial for ALS

A step forward in finding a treatment for a deadly neurological disorder

THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a nasty disease that steadily attacks nerve cells in the brain and spinal cord. It’s pretty much always fatal within a few years. As if that wasn’t bad enough, ALS also can overlap with a … Continue reading A step forward in finding a treatment for a deadly neurological disorder

CIRM supported study of gene silencer blocks ALS degeneration, saves motor function

Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a neurodegenerative disease that destroys the nerve cells in the brain and spinal cord. As a result of ALS, the motor neurons that enable bodily movement and muscle control are harmed, which can make it difficult to move, speak, eat, and breathe. This condition … Continue reading CIRM supported study of gene silencer blocks ALS degeneration, saves motor function

Stem cell model reveals deeper understanding into “ALS resilient” neurons

Understanding the basic biology of how a cell functions can be crucial to being able to better understand a disease and unlock a potential approach for a treatment. Stem cells are unique in that they give scientists the opportunity to create a controlled environment of cells that might be otherwise difficult to study. Dr. Eva … Continue reading Stem cell model reveals deeper understanding into “ALS resilient” neurons

U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board

Larry Goldstein PhD, has many titles, one of which sums up his career perfectly, “Distinguished Professor”. Dr. Goldstein has distinguished himself on many fronts, making him an ideal addition to the governing Board of the California Institute for Regenerative Medicine (CIRM). Dr. Goldstein – everyone calls him Larry – is a Cell Biologist, Geneticist and … Continue reading U.C. San Diego Scientist Larry Goldstein Joins Stem Cell Agency’s Board

The Most Read Stem Cellar Blog Posts of 2021

THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST This year was a momentous one for the California Institute for Regenerative Medicine (CIRM). We celebrated the passage of Proposition 14, and as a result, introduced our new strategic plan and added a group of talented individuals to our team.   We shared our most exciting updates and newsworthy stories—topics ranging from stem cell research to diversity … Continue reading The Most Read Stem Cellar Blog Posts of 2021

Blood-brain barrier chip created with stem cells expands potential for personalized medicine

The brain is a complex part of the human body that allows for the formation of thoughts and consciousness. In many ways it is the essence of who we are as individuals. Because of its importance, our bodies have developed various layers of protection around this vital organ, one of which is called the blood-brain … Continue reading Blood-brain barrier chip created with stem cells expands potential for personalized medicine

A stepping stone for bringing stem cell therapy to patients with ALS

Imagine being told that you have a condition that gradually causes you to lose the ability to control your body movements, from picking up a pencil to walking to even breathing. Such is the reality for the nearly 6,000 people who are diagnosed with amyotrophic lateral sclerosis (ALS) every year, in the United States alone. … Continue reading A stepping stone for bringing stem cell therapy to patients with ALS